Teva-Metoprolol 100 mg – DIN 00842656
Teva-Metoprolol is Metoprolol Tartrate 100 mg (tablet), sold in Canada. It is used for high blood pressure, heart failure and chest pain (angina). It is supplied by Teva Canada Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Metoprolol Tartrate 100 mg
- Brand
- Teva-Metoprolol
- Strength
- 100 mg
- Used for
- High blood pressure, heart failure and chest pain (angina)
- Form
- Tablet
- Manufacturer
- Teva Canada Limited
- Drug class
- Beta blocker (heart and blood pressure medicine)
- Sold in
- Canada
- DIN
- 00842656
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Metoprolol Tartrate used for?
Metoprolol Tartrate is used for high blood pressure, heart failure, chest pain (angina) and atrial fibrillation (irregular heartbeat).
- Medicine type
- Beta blocker (heart and blood pressure medicine)
Official uses from the US prescribing label
Hypertension
Metoprolol tartrate tablets are indicated for the treatment of hypertension in adult patients, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Metoprolol tartrate tablets may be administered with other antihypertensive agents.
Angina Pectoris
Metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance.
Myocardial Infarction
Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.
From the FDA-approved label on DailyMed (published Sep 29, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 00842656.
- It names Teva-Metoprolol, Metoprolol Tartrate 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Teva-Metoprolol uncoated by Teva Canada Limited.
In Canada: prescription only.
Ingredients
Active: Metoprolol Tartrate
Other Metoprolol Tartrate pills
-
C 75
Metoprolol Tartrate 100 mg
Blue, round, 11 mm
Used for high blood pressure and heart failure
-
R100
Metoprolol Tartrate 100 mg
Pink, round, 12 mm
Used for high blood pressure and heart failure
-
C 73
Metoprolol Tartrate 25 mg
White, round, 7 mm
Used for high blood pressure and heart failure
-
R25
Metoprolol Tartrate 25 mg
Pink, round, 7 mm
Used for high blood pressure and heart failure
-
R37 5
Metoprolol Tartrate 37.5 mg
Pink, round, 7 mm
Used for high blood pressure and heart failure
-
M 32
Metoprolol Tartrate 50 mg
Pink, round, 8 mm
Used for high blood pressure and heart failure
-
C 74
Metoprolol Tartrate 50 mg
Pink, round, 8 mm
Used for high blood pressure and heart failure
-
R50
Metoprolol Tartrate 50 mg
Pink, round, 9 mm
Used for high blood pressure and heart failure